All CIRS research papers

7,510 papers, newest first · page 84 of 126

  1. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways?

    Current Opinion in Cardiology · 2004

  2. Faculty Opinions recommendation of Striatal contributions to working memory: a functional magnetic resonance imaging study in humans.

    Eur J Neurosci · 2004

  3. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-10

    The Journal of Immunology · 2004

  4. The specificity of the CDC-1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria

    Annals of Epidemiology · 2004

  5. Prevalence of abnormal; cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-Barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome

    In vivo · 2004

  6. Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res

    2004

  7. Factors influencing the diagnosis of chronic fatigue syndrome

    Archives of Internal Medicine · 2004

  8. Reactive airways dysfunction syndrome in housewives due to a bleach-hydrochloric acid mixture

    Inhalation Toxicology · 2004

  9. Acute respiratory effects of exposure to ammonia on healthy subjects

    Scandinavian Journal of Work Environment & Health · 2004

  10. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions

    Histology and histopathology · 2004

  11. The chronic consequences of severe sepsis

    Journal of Leukocyte Biology · 2004

  12. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile

    Journal of Leukocyte Biology · 2004

  13. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis

    Seminars in Arthritis and Rheumatism · 2004

  14. Mathematical models of the acute inflammatory response

    Computers and Their Applications · 2004

  15. Crosstalk between inflammation and thrombosis

    Maturitas · 2004

  16. Complement activation, endothelin-1 and neuropeptide Y in relation to the cardiovascular response to endotoxin-induced systemic inflammation in healthy volunteers

    Acta Anaesthesiologica Scandinavica · 2004

  17. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system

    Journal of Molecular Endocrinology · 2004

  18. Genetic basis of pulmonary arterial hypertension

    Journal of the American College of Cardiology · 2004

  19. Disruption of transforming growth factor β signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator–activated receptor γ

    Arthritis & Rheumatism · 2004

  20. Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays

    Cellular and Molecular Neurobiology · 2004

  21. Caribbean ciguatera: a changing paradigm

    Rev Biol Trop · 2004

  22. Correction to “Maitotoxin induces biphasic interleukin-1β secretion and membrane blebbing in murine macrophages”

    Mol Pharmacol · 2004

  23. Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides

    Journal of Clinical Investigation · 2004

  24. Chronic stress alters dendritic morphology in rat medial prefrontal cortex

    Journal of Neurobiology · 2004

  25. A role for proinflammatory cytokines in the behavioral disturbances and cognitive decline in chronic renal failure patients

    Clinical Nephrology · 2004

  26. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients

    The Journal of Rheumatology · 2004

  27. The metabolic syndrome, inflammation, and risk of cognitive decline

    El siglo de Europa · 2004

  28. Cytokines and psychopathology: Lessons from interferon-α

    Biological Psychiatry · 2004

  29. Is damage in central nervous system due to inflammation?

    Autoimmunity Reviews · 2004

  30. Clodronate inhibits the secretion of proinflammatory cytokines and NO by isolated microglial cells and reduces the number of proliferating glial cells in excitotoxically injured organotypic hippocampal slice cultures

    Experimental Neurology · 2004

  31. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction?

    Curr Opin Investig Drugs · 2004

  32. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease

    Brain Behavior and Immunity · 2004

  33. Effects of gene delivery on collateral development in chronic hypoperfusionDiverse effects of angiopoietin-1 versus vascular endothelial growth factor

    Journal of the American College of Cardiology · 2004

  34. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia

    Journal of Biological Chemistry · 2004

  35. Biological Activities of Naturally Occurring Antibodies Reactive withCandida albicansMannan

    Infection and Immunity · 2004

  36. An approach to the diagnosis and treatment of cryofibrinogenemia

    The American Journal of Medicine · 2004

  37. Efficacy of a commercial mycotoxins binder in alleviating effects of ochratoxin A, fumonisin B1, moniliformin and zearalenone in adult mink

    Veterinary and human toxicology · 2004

  38. In vitrostudies on the evaluation of mycotoxin detoxifying agents for their efficacy on deoxynivalenol and zearalenone

    Archives of Animal Nutrition · 2004

  39. Cytokine and nitric oxide production following severe envenomation

    Current Drug Targets - Inflammation & Allergy · 2004

  40. Marine Neurotoxins: Envenomations and contact toxins

    Current Treatment Options in Neurology · 2004

  41. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam

    Proceedings of the National Academy of Sciences · 2004

  42. Pilot study to reduce dioxins in the human body

    Internal Medicine · 2004

  43. Haemophore‐mediated signalling in Serratia marcescens: a new mode of regulation for an extra cytoplasmic function (ECF) sigma factor involved in haem acquisition

    Molecular Microbiology · 2004

  44. Morphological manifestations of heart remodeling in anthracycline-induced dilated cardiomyopathy

    Bulletin of Experimental Biology and Medicine · 2004

  45. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice

    Circulation · 2004

  46. Patterns in evolution: veins of the Drosophila wing

    Trends in Genetics · 2004

  47. This paper is a classic in discussion of causal affect in epidemiology. Causation is discussed looking at dichotomous variables with the annulling assumption that no random error attributable to sampling variability exists. This paper present the concept of causal theory. The limitations on randomized studies are reasons why methods for causal inference from observational data are needed. Contrast this proviso to that we see in prospective interventional trials in which using the same dichotomous variables gives the ability to conclude risk and therefore causation

    A definition of causal effect for epidemiological research. J Epidemiol Community Health · 2004

  48. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation

    Epidemiologic Perspectives & Innovations · 2004

  49. Assumptions about unmeasured confounders remain the fundamental flaw of observational studies. More complete empirical evaluations comparing observational methods in different situations are needed

    Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol · 2004

  50. Bias can be defined as a lack of internal validity for an incorrect assessment of association between and exposure and a effect. Bias may be introduced by definition and selection of study population; data collection; and association between different determinates of an effect in the population

    Bias. J Epidemiol Community Health · 2004

  51. Selection bias encompasses various biases in epidemiology. Restriction of information and inappropriate selection controls are two examples of selection bias. This paper is an organized theoretical bases of selection bias. Use of the patient as his own control will eliminate selection bias

    A structural approach to selection bias. Epidemiology · 2004

  52. Erythropoietin: novel approaches to neuroprotection in human brain disease

    Metabolic Brain Disease · 2004

  53. The potential role of vascular endothelial growth factor in the central nervous system

    Reviews in the Neurosciences · 2004

  54. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson’s disease

    European Journal of Neuroscience · 2004

  55. Neurodegeneration or neuroprotection: the pivotal role of astrocytes

    Neurochemical Research · 2004

  56. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways

    Neurosignals · 2004

  57. Erythropoietin (epoetin) as a protective factor for the brain

    Current Atherosclerosis Reports · 2004

  58. Erythropoietin and the nervous system

    Brain Research · 2004

  59. Erythropoietin as an antiapoptotic, tissue-protective cytokine

    Cell Death and Differentiation · 2004

  60. Erythropoietin Attenuates Post-Traumatic Injury in Organotypic Hippocampal Slices

    Journal of Neurotrauma · 2004